Investment Thesis
Avantor exhibits concerning fundamental deterioration with declining revenue (-3.4% YoY), abysmal returns (ROE 0.8%, ROA 0.4%), and razor-thin profitability (2.7% net margin) that leaves minimal margin for error. The 175% EPS collapse combined with low interest coverage (2.3x) and substantial debt ($3.8B) suggests the company is struggling to justify its asset base and may face pressure managing obligations.
Strengths
- Positive free cash flow generation ($25.2M) despite weak profitability
- Reasonable gross margin (31.7%) indicates some production efficiency
- Adequate short-term liquidity with current ratio of 1.76x
Risks
- Accelerating revenue decline (-3.4% YoY) in cyclical sector with no offsetting operational leverage
- Interest coverage ratio of only 2.3x provides insufficient cushion for debt servicing; refinancing risk if conditions worsen
- Severely depressed capital returns (ROE 0.8%, ROA 0.4%) indicate capital is not efficiently deployed across $11.7B asset base
- Massive EPS deterioration (-175% YoY) signals underlying operational distress despite flat net income
- Thin operating margin (6.3%) and net margin (2.7%) offer no buffer for competitive or economic headwinds
Key Metrics to Watch
- Revenue growth trajectory and market share trends in laboratory instruments sector
- Operating margin expansion or contraction in next reporting periods
- Interest coverage ratio trend and debt covenant compliance
- Free cash flow sustainability and capital allocation decisions
Financial Metrics
Revenue
1.6B
Net Income
43.3M
EPS (Diluted)
$0.06
Free Cash Flow
25.2M
Total Assets
11.7B
Cash
279.3M
Profitability Ratios
Gross Margin
31.7%
Operating Margin
6.3%
Net Margin
2.7%
ROE
0.8%
ROA
0.4%
FCF Margin
1.6%
Balance Sheet & Liquidity
Current Ratio
1.76x
Quick Ratio
1.17x
Debt/Equity
0.68x
Debt/Assets
52.1%
Interest Coverage
2.32x
Long-term Debt
3.8B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T14:25:40.596912 |
Data as of: 2026-03-31 |
Powered by Claude AI